Identification and prediction of coronary artery plaque rupture using 18F-fluoride positron emission tomography

Medicine & Life Sciences

1. Troponin I 100%
2. Acute Coronary Syndrome 79%
3. Troponin 78%
4. Aortic Valve Stenosis 72%
5. Computed Tomography Angiography 70%
6. Myocardial Infarction 66%
7. Cardiology 66%
8. Coronary Artery Disease 64%
9. Coronary Angiography 62%
10. Stable Angina 59%
11. Tomography 58%
12. Abdominal Aortic Aneurysm 58%
13. SRT2104 55%
14. ferumoxtran-10 52%
15. Calcinosis 49%
16. Rupture 44%
17. Aortic Valve 44%
18. Magnetic Resonance Spectroscopy 43%
19. Fluorides 43%
20. alovudine 42%
21. Positron-Emission Tomography 41%
22. Ferrosoferric Oxide 40%
23. Heart 39%
24. Apelin 39%
25. Ticagrelor 37%
26. Cell Tracking 37%
27. Angina Pectoris 36%
28. Coronary Vessels 35%
29. Positron Emission Tomography Computed Tomography 35%
30. Aneurysm 35%
31. Myocardium 34%
32. Biological Monitoring 34%
33. Chest Pain 34%
34. Atherosclerotic Plaques 33%
35. ferric oxide 32%
36. Lipoprotein(a) 32%
37. Manganese 31%
38. Pulmonary Arterial Hypertension 31%
39. Vascular Stiffness 30%
40. Gadolinium 29%
41. Inflammation 29%
42. Echocardiography 28%
43. Long Noncoding RNA 28%
44. Heart Transplantation 27%
45. Magnetic Resonance Imaging 27%
46. Pyr(1)-apelin 13 27%
47. Fibrosis 25%
48. Macrophages 25%
49. Tobacco Products 24%
50. Guidelines 24%
51. Hepacivirus 24%
52. Confidence Intervals 24%
53. Phospholipids 23%
54. Meta-Analysis 23%
55. Systematic Reviews 23%
56. Smooth Muscle 23%
57. Multicenter Studies 22%
58. Smokers 22%
59. Placebos 22%
60. Monocytes 21%
61. Deoxyglucose 21%
62. Inbred C57BL Mouse 21%
63. Thorax 21%
64. Hemodynamics 21%
65. Pulse 20%
66. Cell Proliferation 19%
67. Type 2 Diabetes Mellitus 19%
68. Duration of Therapy 19%
69. Virus Diseases 19%
70. Mortality 19%
71. Cardiovascular Diseases 19%
72. Pulse Wave Analysis 18%
73. Cardiomyopathies 18%
74. Wounds and Injuries 18%
75. Blood Pressure 18%
76. Heart Murmurs 17%
77. Clinical Trials 17%
78. Thrombocytosis 17%
79. Therapeutics 17%
80. Wool 17%
81. Ophthalmoscopy 17%
82. Quality of Life 16%
83. Diplopia 15%
84. Aortic Valve Insufficiency 15%
85. Myocardial Ischemia 15%
86. Blood Sedimentation 14%
87. Calcium 14%
88. Syncope 14%
89. Thoracic Wall 14%
90. Safety 13%
91. Angiography 13%
92. C-Reactive Protein 13%
93. Prednisolone 13%
94. Lung 13%
95. Collagen 13%
96. Psychological Handling 13%
97. Thoracic Aorta 13%
98. Odds Ratio 12%
99. Randomized Controlled Trials 12%
100. EVP 1001-1 12%
101. Aortic Rupture 12%
102. Dyspnea 11%
103. Coronary Disease 11%
104. Multimodal Imaging 11%
105. Vascular Smooth Muscle 11%
106. Spatial Navigation 11%
107. Molecular Imaging 11%
108. Anemia 11%
109. Infarction 11%
110. Weight Loss 10%
111. Hypertrophy 10%
112. Cross-Over Studies 10%
113. Graft Rejection 10%
114. Population 10%
115. Electrocardiography 10%
116. Smooth Muscle Myocytes 10%
117. Heart Failure 10%
118. Healthy Volunteers 10%
119. Biomarkers 9%
120. Quality-Adjusted Life Years 9%
121. Contrast Media 9%
122. Type 5 Cyclic Nucleotide Phosphodiesterases 9%
123. Heart Rupture 9%
124. Sample Size 9%
125. Thrombosis 9%
126. N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid 9%
127. Endocarditis 9%
128. Innate Immunity 9%
129. Calcium Compounds 8%
130. Morbidity 8%
131. American Heart Association 8%
132. Cohort Studies 7%
133. Calibration 7%
134. Cost-Benefit Analysis 7%
135. Cardiac Catheterization 6%
136. Eagles 6%
137. Hemorrhage 6%
138. Observational Studies 6%
139. Perfusion 6%
140. Pulmonary Hypertension 6%
141. In Vitro Techniques 6%
142. Injections 6%
143. Chronic Disease 6%
144. Vasodilation 6%
145. Disease Progression 6%
146. Growth 6%
147. Cardiac Output 6%
148. Ventricular Remodeling 6%
149. Vascular Resistance 6%
150. Ligands 6%
151. Transplants 6%
152. Hospital Emergency Service 6%
153. Extracellular Space 5%
154. Apolipoproteins B 5%
155. Brain Natriuretic Peptide 5%
156. Manometry 5%
157. Income 5%
158. Precision Medicine 5%
159. Ischemia 5%
160. Extremities 5%
161. Extracellular Matrix 5%
162. Reference Values 5%
163. Hypoxia 5%
164. Statistics 5%
165. Ultrasonography 5%
166. Standard of Care 5%
167. Platelet-Derived Growth Factor 5%
168. Transplantation 5%